3fuo: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3fuo.png|left|200px]] | [[Image:3fuo.png|left|200px]] | ||
{{STRUCTURE_3fuo| PDB=3fuo | SCENE= }} | {{STRUCTURE_3fuo| PDB=3fuo | SCENE= }} | ||
===The Crystal structure of receptor binding domain of botulinum neurotoxin serotype A=== | ===The Crystal structure of receptor binding domain of botulinum neurotoxin serotype A=== | ||
{{ABSTRACT_PUBMED_19476346}} | {{ABSTRACT_PUBMED_19476346}} | ||
==About this Structure== | ==About this Structure== | ||
[[3fuo]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FUO OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019476346</ref><references group="xtra"/> | ||
[[Category: Bontoxilysin]] | [[Category: Bontoxilysin]] | ||
[[Category: Clostridium botulinum]] | [[Category: Clostridium botulinum]] | ||
Line 38: | Line 26: | ||
[[Category: Metalloprotease]] | [[Category: Metalloprotease]] | ||
[[Category: Neurotoxin]] | [[Category: Neurotoxin]] | ||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
[[Category: Toxin]] | [[Category: Toxin]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
Revision as of 17:21, 20 February 2013
The Crystal structure of receptor binding domain of botulinum neurotoxin serotype AThe Crystal structure of receptor binding domain of botulinum neurotoxin serotype A
Template:ABSTRACT PUBMED 19476346
About this StructureAbout this Structure
3fuo is a 1 chain structure with sequence from Clostridium botulinum. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F. Biochemistry. 2009 Jun 23;48(24):5631-41. PMID:19476346 doi:10.1021/bi9002138